Literature DB >> 20091685

Expression of placenta growth factor: an independent factor for prediction of progression and prognosis of oral cancer.

Shih-Jung Cheng1, Jang-Jaer Lee, Sang-Heng Kok, Chia-Hsuan Chou, Hao-Hueng Chang, Meng Ling Chiang, Hsin-Ming Chen, Mark Yen-Ping Kuo, Chun-Pin Chiang.   

Abstract

BACKGROUND: Expression of placenta growth factor (PlGF) is found to correlate with the progression and prognosis of several human cancers.
METHODS: This study used an immunohistochemical technique to examine the expression of PlGF in 100 specimens of oral squamous cell carcinoma (OSCC).
RESULTS: We found that the higher mean PlGF labeling index was significantly associated with OSCCs with positive lymph node metastasis (p = .014) or with more advanced clinical stages (p = .016). Positive lymph node metastasis (p = .008) and PlGF labeling index >40% (p = .010) were identified as independent unfavorable prognosis factors by multivariate analyses with Cox regression model. Moreover, a Kaplan-Meier curve showed that OSCC patients with a PlGF labeling index >40% had a significantly poorer cumulative survival than those with a PlGF labeling index ≤40% (log-rank test, p = .003).
CONCLUSIONS: The PlGF labeling index can predict the progression and prognosis of OSCCs in Taiwan.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091685     DOI: 10.1002/hed.21335

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.

Authors:  Ulrik Lassen; Olivier L Chinot; Catherine McBain; Morten Mau-Sørensen; Vibeke Andrée Larsen; Maryline Barrie; Patrick Roth; Oliver Krieter; Ka Wang; Kai Habben; Jean Tessier; Angelika Lahr; Michael Weller
Journal:  Neuro Oncol       Date:  2015-02-09       Impact factor: 12.300

2.  Placenta growth factor expression is regulated by hydrogen peroxide in vascular smooth muscle cells.

Authors:  Jennifer H Shaw; Lingjin Xiang; Anu Shah; Wei Yin; Pamela G Lloyd
Journal:  Am J Physiol Cell Physiol       Date:  2010-12-01       Impact factor: 4.249

3.  Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.

Authors:  Amy Anne D Lassig; Anne M Joseph; Bruce R Lindgren; Bevan Yueh
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-07-01       Impact factor: 6.223

4.  Arsenite-mediated promotion of anchorage-independent growth of HaCaT cells through placental growth factor.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Shoko Ohnuma; Nobutaka Ohgami; Hisao Naito; Hossain U Shekhar; Yasuhiro Omata; Masashi Kato
Journal:  J Invest Dermatol       Date:  2014-12-10       Impact factor: 8.551

5.  Prognostic significance of placenta growth factor expression in patients with multiple cancers: a meta-analysis.

Authors:  Fan-Jun Meng; Shu-Xin Xiao; Yan Zhang; Wei Wang; Bin Wang; Xin-Yi Fan
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Characterization of the Expression of Angiogenic Factors in Cutaneous Squamous Cell Carcinoma of Domestic Cats.

Authors:  Erwin Kristobal Gudenschwager-Basso; Valentina Stevenson; Dan Phillip Sponenberg; Thomas E Cecere; William R Huckle
Journal:  Vet Sci       Date:  2022-07-21

7.  Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients.

Authors:  Vishwajith Sridharan; Danielle N Margalit; Stephanie A Lynch; Mariano Severgnini; F Stephen Hodi; Robert I Haddad; Roy B Tishler; Jonathan D Schoenfeld
Journal:  J Immunother Cancer       Date:  2016-06-21       Impact factor: 13.751

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.